Cardiovascular Devices Market Global Report 2017

Cardiovascular Devices Market Global Report 2017

  • July 2017 •
  • 250 pages •
  • Report ID: 4693475 •
  • Format: PDF
Cardiovascular devices are designed to diagnose, prevent, monitor and treat diseases related to the cardiovascular system, including heart diseases and related health problems. They include arrhythmia detectors, noninvasive blood pressure measurement systems, diagnostic intravascular catheters, external cardiac compressors, coronary vascular physiologic simulation software devices, external programmable pacemaker pulse generators, cardiac monitors, cardiopulmonary bypass defoamers, echocardiographs, vascular graft prostheses, electrocardiographs, defibrillators and others.

Americas was the largest region in the cardiovascular devices market in 2016, accounting for over 47% of the market share. Asia was the second largest region accounting for around 25% of the market share. Europe was the third largest region accounting for over 20% of the market share.

Companies in the market are focusing on R&D. Areas of development include pacemakers, coronary stents, angioplasty products and implantable cardiac defibrillators. For instance, introduction of bio absorbable vascular stents in percutaneous coronary interventions is promising. In July 2016, the FDA approved the first fully absorbable stent, Absorb GT1 BVS manufactured by Abbott Vascular for coronary artery disease. It offers a new treatment option for patients undergoing angioplasty and opting for absorbable devices instead of metallic stents. In April 2016, FDA approved the world’s first leadless pacemaker, Micra Transcatheter Pacemaker System to treat heart rhythm disorders, which is manufactured by Medtronic Plc. This pacemaker can deliver percutaneously directly into the right ventricle through a minimally invasive approach, and does not require the use of wired leads in providing electrical connection between heart and pulse-generating devices.